Komtur Pharmaceuticals Headquarters
Am Flughafen 6
DE 79108 Freiburg im Breisgau
Telephone: +49(0)761 504 23 0
Fax: +49(0)761 504 23 15
E-Mail: info@komtur.com

Komtur Pharmaceuticals is a specialized pharmaceutical wholesaler who has been acting successfully on the international pharmaceutical market for over fifty years. We supply patients around the world with urgently needed drugs and carry out complex projects on behalf of pharmaceutical companies.

Our international team of pharmacists, qualified pharmaceutical personnel, and experienced logisticians as well as service employees is intimately familiar with the options, challenges, and regulatory requirements of the national and global pharmaceuticals trade.

Our name stands for custom-tailored solutions for supplying international drugs, sourcing and distributing trial medication, or market launching your innovative drug.

We never forget that every shipment is destined for a patient with individual needs.

From its origins as the Komtur Pharmacy in Freiburg, our company has grown to representation in six countries on three continents with over 65 employees. All subsidiaries of the Komtur Group are in constant contact with one another and work in close consultation with the company headquarters in Freiburg (Breisgau), Germany. Although our roots are in Freiburg, we are represented in core markets of our industry with our subsidiaries. This keeps us continuously updated about innovations of all kinds, new drug developments, or better transport routes.

With the exception of Shanghai, all of our subsidiaries are fully licensed pharmaceutical wholesalers.

The Komtur portfolio includes:

Our customers and partners in Germany and abroad know and appreciate Komtur Pharmaceuticals as a reliable and innovative specialized pharmaceutical wholesaler. Our aim is to keep earning your appreciation.

Go to article: Home | The Scottish Uprising Go to article: In this issueGo to article: NSFGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: Hapa Company InsightGo to article: BioadviceGo to article: The pharma industry briefingGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: Where is the UK’s supply of Migraleve?Go to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Drugs from corn? Harvesting Mirexus’ phytoglycogen nano-particleGo to article: Phoenix Group Company InsightGo to article: Phoenix Group Go to article: Castleman disease: does machine learning hold the key to better treatment?Go to article: Capsugel Company InsightGo to article: CalleryGo to article: A health check for Scotland’s pharmaceutical industry Go to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Moderna’s gamble: what’s behind biotech’s biggest-ever IPO?Go to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: DelSiTech: leveraging silica’s properties to improve drug deliveryGo to article: Alpex Pharma Go to article: AlbypharmaGo to article: ‘Gene genie’: can CRISPR/Cas9 deliver on its promise to transform genome therapy?Go to article: ZenatekGo to article: EventsGo to article: SanofiGo to article: Event: CPhl JapanGo to article: PfanstiehlGo to article: Next issue